Clinical trials
Recruiting Lymphoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 8 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 17 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 54 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 3 |
| Dana-Farber Cancer Institute | 2 |
| Hebei Senlang Biotechnology Inc., Ltd. | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| University Health Network, Toronto | 2 |
| University Hospital, Angers | 2 |
| University of Miami | 2 |
| University of Nebraska | 2 |
| AC Camargo Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 54 |
| Multiple Myeloma | 17 |
| Leukemia | 13 |
| Neoplasms | 11 |
| Breast Neoplasms | 9 |
| Hematologic Neoplasms | 7 |
| Colorectal Neoplasms | 5 |
| Myelodysplastic Syndromes | 5 |
| Colonic Neoplasms | 4 |
| Lymphoma, B-Cell | 4 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.